Taiwan FDA registration a4df6d8c85e5b1e39dcde59fb009b269

"Boston Scientific" Tux paclitaxel-releasing coronary stent system

TW: "波士頓科技"塔克斯紫杉醇釋放型冠狀動脈支架系統
Taiwan flagTaiwan·Risk Class 3·Boston Scientific Limited·Registered May 04, 2006 – May 04, 2021Cancelled
Registration details
Analysis ID
a4df6d8c85e5b1e39dcde59fb009b269
Customs Code
DHA00601440206
Company information
Manufacturer Country
Ireland
Product details
Intended Use
For details, it is Chinese approved copy of the imitation order. For details, it is Chinese approved copy of the imitation order.
Product Type (Level 1)
E Cardiovascular Medicine Science
Product Type (Level 2)
E.0001 Cardiovascular stents
Import Information
import
Dates and status
Registration Date
May 04, 2006
Expiry Date
May 04, 2021
Cancellation Date
Aug 23, 2023
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
Companies making similar products

Top companies providing products similar to ""Boston Scientific" Tux paclitaxel-releasing coronary stent system"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for "Boston Scientific" Tux paclitaxel-releasing coronary stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a4df6d8c85e5b1e39dcde59fb009b269 and manufactured by Boston Scientific Limited. The authorized representative in Taiwan is Dutch Boston Technology Co., Ltd. Taiwan Branch.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BOSTON SCIENTIFIC IRELAND LTD., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations